Domain structure of pleiotrophin required for transformation

J Biol Chem. 1999 May 7;274(19):12959-62. doi: 10.1074/jbc.274.19.12959.

Abstract

The pleiotrophin (PTN) gene (Ptn) is a potent proto-oncogene that is highly expressed in many primary human tumors and constitutively expressed in cell lines derived from these tumors. The product of the Ptn gene is a secreted 136-amino acid heparin binding cytokine with distinct lysine-rich clusters within both the N- and C-terminal domains. To seek domains of PTN functionally important in neoplastic transformation, we constructed a series of mutants and tested their transforming potential by four independent criteria. Our data establish that a domain within PTN residues 41 to 64 and either but not both the N- or C-terminal domains are required for transformation; deletion of both the N and C termini abolishes the transformation potential of PTN. Furthermore, deletion of two internal 5-amino acid residue repeats enhances the transformation potency of PTN 2-fold. Our data indicate that PTN residues 41-64 contain an essential domain for transformation and suggest the hypothesis that this domain requires an additional interaction of the highly basic clusters of the N or C terminus of PTN with a negatively charged "docking" site to enable the transforming domain itself to engage and initiate PTN signaling through its cognate receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Amino Acid Sequence
  • Animals
  • Carrier Proteins / chemistry*
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cell Transformation, Neoplastic
  • Cytokines / chemistry*
  • Cytokines / genetics
  • Cytokines / metabolism
  • Humans
  • Mice
  • Mice, Nude
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Neoplasm Transplantation
  • Neoplasms, Experimental / pathology
  • Proto-Oncogene Mas

Substances

  • Carrier Proteins
  • Cytokines
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • pleiotrophin